InsidersTradesSigma
Gubra A/S Stock: price and directors' dealings · Denmark · Finanstilsynet DK
Track the Gubra A/S share price and the full insider trade history of the company, a listed equity based in Denmark. Shares are quoted on DK DK, under the authority of Finanstilsynet DK. Operating in the Healthcare & Pharma sector, Gubra A/S has recorded 34 reports. Market capitalisation: €5.3bn. The latest transaction was disclosed on 17 June 2026 (Other). Among the most active insiders: Unknown. The full history is openly available.
34
Insider Decl.
0
Thresholds
€4m
13 ops.
Buy Volume
€25m
4 ops.
Sell Volume
35Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 7 of 26,092 companies
97.3
score / 100
Value97
Quality97
FCF yld29%
Earn yld28%
EV/EBITDA2.8x
ROE212%
Gross mgn97%
Net mgn64%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 17 June 2026
Declarations34 total
138 shares@ DKK 358.520.0001% mcap2.3% of flowShareNASDAQ CopenhagenDK:1448725
1,312 shares@ DKK 358.520.0011% mcap22.7% of flowShareNASDAQ CopenhagenDK:1448724
2,500 shares@ DKK 339.380.0020% mcap52.9% of flowShareNASDAQ CopenhagenDK:1447498
20,189 shares@ DKK 37.39170.0018% mcap47.1% of flowShareOutside a trading venueDK:1447497
7 shares@ €1.0854ShareOutside a trading venueDK:1446387
7 shares@ €4.1625ShareOutside a trading venueDK:1446385
1,425 shares@ DKK 321.2080.0012% mcap0.1% of flowShareNASDAQ CopenhagenDK:1441280
Ideal exit: 2 Feb 2027 (T+270)
20,000 shares@ DKK 381.37252.4% of flowShareNASDAQ CopenhagenDK:1423694
Ideal exit: 27 Nov 2026 (T+270)
10,000 shares@ DKK 487.99770.012% mcap1.5% of flowShareNASDAQ CopenhagenDK:1406879
Ideal exit: 13 Sept 2026 (T+270)
385 shares@ DKK 387.820.038% mcap4.6% of flowShareNASDAQ CopenhagenDK:1399826
Ideal exit: 4 Aug 2026 (T+270)
379 shares@ DKK 392.620.0004% mcap0.0% of flowShareNASDAQ CopenhagenDK:1399794
Ideal exit: 4 Aug 2026 (T+270)
4,300 shares@ DKK 373.610.0040% mcap0.5% of flowShareNASDAQ CopenhagenDK:1399538
Ideal exit: 4 Aug 2026 (T+270)
6,385 shares0ShareOutside a trading venueDK:1377391
11,186 shares0ShareOutside a trading venueDK:1377390
532 shares@ DKK 530.000.0040% mcap0.5% of flowShareNASDAQ Copenhagen A/SDK:1305914
53,000 shares@ DKK 576.000.077% mcap9.5% of flowShareOutside a trading venueDK:1304823
306 shares@ DKK 478.000.0004% mcap0.0% of flowShareNASDAQ Copenhagen A/SDK:1304004
Ideal exit: 25 Mar 2025 (T+270)
7,291 shares0ShareOutside a trading venueDK:1300084
12,245 shares0ShareOutside a trading venueDK:1300083
6,818 shares0ShareOutside a trading venueDK:1285571
Ideal exit: 29 Dec 2024 (T+270)
10,909 shares0ShareOutside a trading venueDK:1285570
Ideal exit: 29 Dec 2024 (T+270)
280 shares@ DKK 284.000.0002% mcap0.0% of flowShareNASDAQ CopenhagenDK:1284343
Ideal exit: 22 Dec 2024 (T+270)
500,000 shares@ DKK 300.000.38% mcap46.5% of flowShareOutside a trading venueDK:1283502
889 shares@ DKK 215.330.0005% mcap0.1% of flowShareNASDAQ Copenhagen ADK:1279111
Ideal exit: 29 Nov 2024 (T+270)
20,189 shares0ShareOutside a trading venueDK:1231786
25 of 34 declarations
About Gubra A/S
Gubra A/S is a Danish company focused on research and development of treatments for metabolic diseases. It emphasizes innovation in the healthcare and pharmaceutical sectors.
